169 related articles for article (PubMed ID: 37395000)
21. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
[TBL] [Abstract][Full Text] [Related]
22. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
23. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
Shekari N; Baradaran B; Shanehbandi D; Kazemi T
Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
[TBL] [Abstract][Full Text] [Related]
24. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721
[TBL] [Abstract][Full Text] [Related]
25. Glycosylation of serum haptoglobin as a marker of gastric cancer: an overview for clinicians.
Jeong S; Oh MJ; Kim U; Lee J; Kim JH; An HJ
Expert Rev Proteomics; 2020 Feb; 17(2):109-117. PubMed ID: 32149536
[No Abstract] [Full Text] [Related]
26. Novel urinary protein biomarker panel for early diagnosis of gastric cancer.
Shimura T; Dayde D; Wang H; Okuda Y; Iwasaki H; Ebi M; Kitagawa M; Yamada T; Yamada T; Hanash SM; Taguchi A; Kataoka H
Br J Cancer; 2020 Nov; 123(11):1656-1664. PubMed ID: 32934343
[TBL] [Abstract][Full Text] [Related]
27. A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer.
Izumi D; Gao F; Toden S; Sonohara F; Kanda M; Ishimoto T; Kodera Y; Wang X; Baba H; Goel A
EBioMedicine; 2019 Mar; 41():268-275. PubMed ID: 30772302
[TBL] [Abstract][Full Text] [Related]
28. Circulating exosomal small RNAs are promising non-invasive diagnostic biomarkers for gastric cancer.
Ge L; Zhang N; Li D; Wu Y; Wang H; Wang J
J Cell Mol Med; 2020 Dec; 24(24):14502-14513. PubMed ID: 33169519
[TBL] [Abstract][Full Text] [Related]
29. Detection of precancerous gastric lesions and gastric cancer through exhaled breath.
Amal H; Leja M; Funka K; Skapars R; Sivins A; Ancans G; Liepniece-Karele I; Kikuste I; Lasina I; Haick H
Gut; 2016 Mar; 65(3):400-7. PubMed ID: 25869737
[TBL] [Abstract][Full Text] [Related]
30. Potential diagnostic and prognostic value of plasma long noncoding RNA LINC00086 and miR-214 expression in gastric cancer.
Ji B; Huang Y; Gu T; Zhang L; Li G; Zhang C
Cancer Biomark; 2019; 24(2):249-255. PubMed ID: 30689553
[TBL] [Abstract][Full Text] [Related]
31. Liquid biopsy for gastric cancer: Techniques, applications, and future directions.
Díaz Del Arco C; Fernández Aceñero MJ; Ortega Medina L
World J Gastroenterol; 2024 Mar; 30(12):1680-1705. PubMed ID: 38617733
[TBL] [Abstract][Full Text] [Related]
32. A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions.
Xu ZQ; Broza YY; Ionsecu R; Tisch U; Ding L; Liu H; Song Q; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD; Leja M; Haick H
Br J Cancer; 2013 Mar; 108(4):941-50. PubMed ID: 23462808
[TBL] [Abstract][Full Text] [Related]
33. Hsa_circ_0065149 is an Indicator for Early Gastric Cancer Screening and Prognosis Prediction.
Shao Y; Tao X; Lu R; Zhang H; Ge J; Xiao B; Ye G; Guo J
Pathol Oncol Res; 2020 Jul; 26(3):1475-1482. PubMed ID: 31432324
[TBL] [Abstract][Full Text] [Related]
34. Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer.
Fan H; Li X; Li ZW; Zheng NR; Cao LH; Liu ZC; Liu MW; Li K; Wu WH; Li ZX; Zhou T; Zhang Y; Liu WD; Zhang LF; You WC; Wang Y; Wu J; Pan KF; Qin J; Li WQ
EBioMedicine; 2022 Dec; 86():104340. PubMed ID: 36356476
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study.
Kanda M; Suh YS; Park DJ; Tanaka C; Ahn SH; Kong SH; Lee HJ; Kobayashi D; Fujiwara M; Shimada H; Cho B; Murotani K; Kim HH; Yang HK; Kodera Y
Gastric Cancer; 2020 Mar; 23(2):203-211. PubMed ID: 31377880
[TBL] [Abstract][Full Text] [Related]
36. Targeted Metabolomic Profiling of Plasma Samples in Gastric Cancer by Liquid Chromatography-Mass Spectrometry.
Matsumoto T; Fukuzawa M; Itoi T; Sugimoto M; Aizawa Y; Sunamura M; Kawai T; Nemoto D; Shinohara H; Muramatsu T; Suzuki Y; Kagawa Y; Suguro M; Uchida K; Koyama Y; Madarame A; Morise T; Yamaguchi H; Sugimoto A; Yamauchi Y; Kono S; Naito S
Digestion; 2023; 104(2):97-108. PubMed ID: 36404717
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic signatures in gastric cancer: current knowledge and future perspectives.
Sogutlu F; Pekerbas M; Biray Avci C
Expert Rev Mol Diagn; 2022 Dec; 22(12):1063-1075. PubMed ID: 36522183
[TBL] [Abstract][Full Text] [Related]
38. Hsa_circ_0001020 Serves as a Potential Biomarker for Gastric Cancer Screening and Prognosis.
Yan J; Shao Y; Lu H; Ye Q; Ye G; Guo J
Dig Dis Sci; 2022 Aug; 67(8):3753-3762. PubMed ID: 34424459
[TBL] [Abstract][Full Text] [Related]
39. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.
Ahadi A
Immunogenetics; 2021 Apr; 73(2):155-161. PubMed ID: 33399935
[TBL] [Abstract][Full Text] [Related]
40. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
